Ozole 20mg Capsule contains Omeprazole, a proton pump inhibitor (PPI) indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions associated with excessive gastric acid secretion. Omeprazole acts by irreversibly inhibiting the H+/K+ ATPase enzyme system located on the gastric parietal cells, thereby suppressing the final step of acid production and effectively reducing gastric acidity. This reduction in acid secretion promotes healing of acid-related damage to the esophageal and gastric mucosa and alleviates symptoms such as heartburn, acid regurgitation, and epigastric pain. Ozole 20mg is typically administered orally once daily before meals, with the dosage and duration tailored according to the specific indication and patient response. It is generally well tolerated, with common adverse effects including headache, abdominal pain, nausea, and diarrhea. Caution is advised in patients with hepatic impairment, and long-term use should be monitored due to potential risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Ozole 20mg Capsule should be used under medical supervision, ensuring appropriate diagnosis and monitoring for optimal therapeutic outcomes.